Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

The strong becomes stronger

The A2 Milk Company
3:27pm
February 17, 2025
Despite supply constraints and other external and market headwinds, A2M continues to execute well, reporting a stronger than expected 1H25 result. FY25 guidance was upgraded and implies that A2M’s sales and margins will accelerate and expand in the 2H25. After strong share price appreciation, we think the company is fairly valued and maintain a Hold rating.

1H25 lacking a spark, but operationally well on the way

LGI
3:27pm
February 17, 2025
LGI got off to a weaker start to FY25, delivering 1H25 revenue growth of +6.7%; EBITDA +3%; and NPAT -22.5% to A$2.4m (A$3.1m pcp). Despite a softer 1H25 financial result, LGI remains operationally on track: winning five new contracts (adding seven sites); completing its Mugga Lane (ML) upgrade (capacity expanded by ~50% to 6MW); furthering its progress at Eastern Creek (Bingo); and 14MW of batteries expected to be delivered in 1H FY26 to ML. LGI reaffirmed its FY25 guidance for EBITDA growth of 12-15%. The group should benefit from a seasonally stronger 2H, given a) higher electricity pricing; b) extra capacity at ML; and c) a small contribution from Bingo in late 2H FY25. We see the next 12-18 months as a catalyst rich period for LGI, as the group continues to progress on its multi-year capex program to 3x its MW under management and drive a structural uplift in EPS. Add maintained.

Debt financing proposal

The Star Entertainment Group
3:27pm
February 17, 2025
The Star Entertainment Group (SGR) has received a $650m debt financing proposal from Oaktree Capital, offering two loan facilities with a 5-year term. This offer comes with a variety of conditions including government and existing lender agreements, however, does not require SGR to raise subordinated capital or any deferment of state taxes. The company is still expected to report on 28 February. Following a review of our research universe, we revise our coverage approach for SGR. While we will continue to monitor and provide updates, we will cease providing a rating, valuation and forecasts. Our forecasts, target price and recommendation should no longer be relied upon for investment decisions.

Prior price support softening

New Hope Group
3:27pm
February 17, 2025
2Q underlying EBITDA beat our forecasts slightly due mainly to lower costs. No changes to FY25 guidance offers comfort amid a falling price environment, particularly given NHC’s cost/ margin advantages versus direct peers. NHC’s defensive attributes – cash margins, balance sheet, steady dividends – has supported outperformance versus peers, but very sluggish NEWC pricing dynamics does now challenge the prior price floor. NHC looks too cheap and remains an Add but lacks a near-term catalyst.

On the acquisition trail

Intelligent Monitoring Group
3:27pm
February 17, 2025
IMB announced that it has entered into an agreement to acquire Kobe Pty Ltd for 3.5x EBITDA (2.8x upfront consideration). This is consistent with the acquisition strategy detailed in November when IMB raised $20m to acquire DVL and confirmed that it had commenced discussions to acquire a further five businesses. We have taken the opportunity to fine-tune our interest costs for FY25. While we had originally forecasted some interest cost savings in FY25 due to the re-financing, these will be offset by some amortisation costs (original fees and warranties) which means net interest in FY25 is expected to be largely the same as FY24. Following these adjustments, our target price rises from 70cps to 75cps. We now forecast EPS growth of +10% in FY25 and +63% in FY26. The stock is trading on <6x FY26 PE, which is too cheap given the growth outlook, cash generation potential and balance sheet capacity. IMB has received full documentation for a new debt facility with NAB. This will provide an additional $37.5m of debt capacity (new facility is $122.5m vs existing $80m) at half the interest rate (new facility ~7% vs existing 15%). The interest rate was at the lower end of our expectations for 7-8% and will result in a material reduction in interest expense (>$6.5mpa). Implementation is expected by the end of March. The reduction in interest expense (>$6.5m) adds at least 1.9cps of EPSA which is +36% vs FY24 (5.3cps). We have taken the opportunity to fine-tune our interest costs for FY25. While we had originally forecasted some interest cost savings in FY25 due to the re-financing, these will be offset by some amortisation costs (original fees and warranties) which means net interest in FY25 is expected to be largely the same as FY24 (~$16m). From FY26, the savings will take full effect and interest costs will halve to just ~$8m.

Improving cash receipts although cash is tight

Control Bionics
3:27pm
February 17, 2025
CBL posted 2Q25 cashflow report noting customer receipts of A$1.4m (up 30% on pcp) and operating cash outflow of A$1.7m. CBL finished the quarter with a cash balance of A$1.0m. During the quarter the company completed a A$2.3m capital raising. Management expect the cash flow in subsequent quarters to improve reflecting cost reductions, stronger US sales and improved NDIS approvals. We are continually reviewing our Healthcare coverage list. At this time we will remove CBL from our Keeping Stock coverage.

Model update

Orora
3:27pm
February 16, 2025
We found an error in our model which resulted in an incorrect calculation of our net interest expense and tax estimates for FY26 and FY27. Our FY25 forecasts were unaffected. After updating our net interest expense and tax estimates, underlying NPAT in FY25F remains unchanged while FY26F rises by 8% and FY27F increases by 7%. We make no changes to other assumptions (ie revenue, EBITDA and EBIT). Our PE-based target price increases to $2.32 (from $2.15) on the back of the updates to earnings forecasts. In our view, ORA is a solid, defensive business with good global market positions in beverages and a strong balance sheet that provides capacity for further organic growth investments. We see potential upside from increased takeover interest in the company and downside if our assumptions of a recovery in FY26 earnings fail to materialise. On balance, we think the current share price broadly reflects the range of possible outcomes and maintain our Hold rating. Upside risks include better-than-expected revenue growth, margins and cost synergies from the Saverglass acquisition as well as a takeover offer for the company. Downside risks include weaker-than-expected global economic growth, higher raw materials and energy prices, and Saverglass earnings, integration and cost synergy targets not being met.

Not alone, but disappointing

GrainCorp
3:27pm
February 16, 2025
GNC’s FY25 earnings guidance was well below consensus. The bigger issue was that despite benefiting from the 4th largest east coast grain crop on record, the mid-point of guidance was well below GNC’s ‘through-the-cycle’ EBITDA guidance. GNC is being impacted by below average grain trading and crush margins. While the seasonal outlook for FY26 appears somewhat favourable over coming months, there is a long way to go until this crop will be harvest. We maintain a Hold rating with a new price target of A$8.04.

More project delays

Civmec
3:27pm
February 16, 2025
The 1H result was disappointing, not least due to a soft 2Q where both revenue and margins faded materially QoQ, but also because of more negative outlook commentary. Although management had already provided that lower levels of activity should be expected in 3Q and potentially into 4Q, a “shift in market conditions” may now see this extend into 2H26. This has culminated in a sharp decline in the order book to just $633m from $1bn in the pcp and $800m at 1Q. An energy project was the main issue; however, iron ore work, which is CVL’s main battleground, is also seeing delays. While CVL is a high-quality contracting business, outside of a large naval shipbuilding award (Landing Craft Heavy), for which the timing is uncertain, our view is that there’s a lack of near-term catalysts to propel the share price higher. We cut our FY25 EPS forecast by nearly 20%, which sees our target price decline to $1.10 (from A$1.40). Move to Hold.

1H mixed - Hearing improvement needed in Services

Cochlear
3:27pm
February 16, 2025
1H results were mixed and quality poor, with net profit in line, but on softer than expected sales as underlying margins were supported by other income. Cochlear Implants (CI) slowed on soft Emerging Market (EM) tenders offsetting Development Market (DM) growth, although favourable product mix supported sales, while Services went backwards on waning Nucleus 8 (N8) sound processor upgrades and US “cost of living” pressures, and Acoustics surprised to the upside. While FY25 guidance is targeting the lower end of the range, we see risk in Services reigniting growth in front of a mid-cycle launch and inflationary headwinds, ongoing uncertainties around CI audiological capacity, and increasing margin headwinds on higher IT spend, limiting operating leverage and strong profitable growth. FY25-27 net profit falls up to 5.9%, with our target price falling to A$285.55. HOLD.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more